BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9501048)

  • 1. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
    Borel C; Sunyach C; Hantz O; Trepo C; Kay A
    Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor envelope proteins of duck hepatitis B virus are initiated at internal pre-S AUG codons but are not essential for infectivity.
    Fernholz D; Wildner G; Will H
    Virology; 1993 Nov; 197(1):64-73. PubMed ID: 8212596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.
    Civitico GM; Locarnini SA
    Virology; 1994 Aug; 203(1):81-9. PubMed ID: 8030288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
    J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization.
    Sunyach C; Chassot S; Jamard C; Kay A; Trepo C; Cova L
    Virology; 1997 Aug; 234(2):291-9. PubMed ID: 9268160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duck hepatitis B virus replication in primary bile duct epithelial cells.
    Lee JY; Culvenor JG; Angus P; Smallwood R; Nicoll A; Locarnini S
    J Virol; 2001 Aug; 75(16):7651-61. PubMed ID: 11462037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
    Yao Y; Tang N; Huang A
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on pathogenicity of precore mutants in Hepadnaviridae.
    Ma Z; Wen Y; Xiong S; Zhai W; He L; Yao X
    Chin Med J (Engl); 1998 Jun; 111(6):519-23. PubMed ID: 11245071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
    Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
    Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis.
    von Weizsäcker F; Köck J; Wieland S; Offensperger WB; Blum HE
    Hepatology; 1999 Jul; 30(1):308-15. PubMed ID: 10385672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
    Chen X; Chen H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
    Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo].
    He L; Wu X; Chen C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning.
    Chassot S; Lambert V; Kay A; Godinot C; Trepo C; Cova L
    Virology; 1994 Apr; 200(1):72-8. PubMed ID: 7510440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.
    Chojnacki J; Anderson DA; Grgacic EV
    J Virol; 2005 Dec; 79(23):14945-55. PubMed ID: 16282493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein.
    von Weizsäcker F; Wieland S; Blum HE
    Hepatology; 1996 Aug; 24(2):294-9. PubMed ID: 8690395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of DNA vaccines against duck hepatitis B virus infection.
    Triyatni M; Jilbert AR; Qiao M; Miller DS; Burrell CJ
    J Virol; 1998 Jan; 72(1):84-94. PubMed ID: 9420203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.